Efficacy and Safety of Roxadustat for Treatment of Anemia in Participants With Lower Risk Myelodysplastic Syndrome With Low Red Blood Cell Transfusion Burden

Clinical trial NCT03263091 · TERMINATED

Trial details

NCT number: NCT03263091
Sponsor: Kyntra Bio
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Primary MDS (Very Low, Low or Intermediate IPSS-R With <5% Blasts)Anemia

Start date: 2018-01-29
Primary completion: 2023-03-09
Enrollment: 184

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.